BioCentury
ARTICLE | Clinical News

Epanova: Phase I/II started

November 15, 2010 8:00 AM UTC

Omthera began the open-label, 4-way crossover, U.S. Phase I/II ECLIPSE trial to compare 4 g Epanova vs. 4 g Lovaza omega-3-acid ethyl esters in about 50 healthy volunteers after a low- and high-fat m...